BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10697268)

  • 1. Metastatic minimally invasive (encapsulated) follicular and Hurthle cell thyroid carcinoma: a study of 34 patients.
    Goldstein NS; Czako P; Neill JS
    Mod Pathol; 2000 Feb; 13(2):123-30. PubMed ID: 10697268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicular carcinoma.
    Franssila KO; Ackerman LV; Brown CL; Hedinger CE
    Semin Diagn Pathol; 1985 May; 2(2):101-22. PubMed ID: 3843689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicular thyroid carcinoma: histology and prognosis.
    D'Avanzo A; Treseler P; Ituarte PH; Wong M; Streja L; Greenspan FS; Siperstein AE; Duh QY; Clark OH
    Cancer; 2004 Mar; 100(6):1123-9. PubMed ID: 15022277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases.
    Ghossein RA; Hiltzik DH; Carlson DL; Patel S; Shaha A; Shah JP; Tuttle RM; Singh B
    Cancer; 2006 Apr; 106(8):1669-76. PubMed ID: 16534796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma.
    Mai KT; Khanna P; Yazdi HM; Perkins DG; Veinot JP; Thomas J; Lamba M; Nair BD
    Pathology; 2002 Jun; 34(3):239-44. PubMed ID: 12109784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why do frozen sections have limited value in encapsulated or minimally invasive follicular carcinoma of the thyroid?
    Leteurtre E; Leroy X; Pattou F; Wacrenier A; Carnaille B; Proye C; Lecomte-Houcke M
    Am J Clin Pathol; 2001 Mar; 115(3):370-4. PubMed ID: 11242793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
    Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
    Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hürthle cell tumors: a twenty-five-year experience.
    Arganini M; Behar R; Wu TC; Straus F; McCormick M; DeGroot LJ; Kaplan EL
    Surgery; 1986 Dec; 100(6):1108-15. PubMed ID: 3787466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid.
    Erickson LA; Jin L; Goellner JR; Lohse C; Pankratz VS; Zukerberg LR; Thompson GB; van Heerden JA; Grant CS; Lloyd RV
    Mod Pathol; 2000 Feb; 13(2):186-92. PubMed ID: 10697277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follicular and Hürthle cell carcinoma: predicting outcome and directing therapy.
    Sanders LE; Silverman M
    Surgery; 1998 Dec; 124(6):967-74. PubMed ID: 9854570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
    Gemsenjäger E; Heitz PU; Martina B; Schweizer I
    Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
    Furlan JC; Bedard YC; Rosen IB
    J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in follicular carcinoma of the thyroid.
    Jorda M; Gonzalez-Campora R; Mora J; Herrero-Zapatero A; Otal C; Galera H
    Arch Pathol Lab Med; 1993 Jun; 117(6):631-5. PubMed ID: 8503737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
    McCaffrey JC
    Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hurthle cell neoplasm of the thyroid gland.
    Ahmed M; Bin Yousef H; Greer W; Faraz H; Al Sobhi S; Al Zahrani A; Raef H; Al Ghamdi A; Al Kadhi Y; Al Dayel F
    ANZ J Surg; 2008 Mar; 78(3):139-43. PubMed ID: 18269475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular and capsular pseudoinvasion in thyroid neoplasms.
    Chebib I; Opher E; Richardson ME
    Int J Surg Pathol; 2009 Dec; 17(6):449-51. PubMed ID: 19666948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of tumor capsular invasion in well-differentiated thyroid carcinomas.
    Furlan JC; Bedard YC; Rosen IB
    Am Surg; 2007 May; 73(5):484-91. PubMed ID: 17521005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
    Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
    Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of frozen section in intraoperative surgical management of thyroid follicular carcinoma.
    Dosen D; Turić M; Smalcelj J; Janusić R; Grgić MP; Separović V
    Head Neck; 2003 Jul; 25(7):521-8. PubMed ID: 12808654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrofollicular variant of follicular thyroid carcinoma: a clinical, cytologic, morphologic, and image analysis study of a unique case.
    Bongiovanni M; Gremaud M; Moulin CS; Scheidegger C; Biton C; Clément S
    Ann Diagn Pathol; 2009 Apr; 13(2):101-5. PubMed ID: 19302958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.